A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22407780
Conclusion of this study
More importantly, curcumin treatment was found to be safe and did not relate with any adverse events. Our study provides the first evidence for the safety and superiority of curcumin treatment in patients with active RA, and highlights the need for future large-scale trials to validate these findings in patients with RA and other arthritic conditions.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study